Paul Glavine purchased 90,000 Cybin common shares at $11.5853 each for $1,042,677 and received 1,046,899 restricted stock units. The transactions sit within a reported 5.8% beneficial interest held by Glavine and PLG Family Trust, giving investors a precise view of direct, trust-linked and award-related exposure.
Key Highlights
- Paul Glavine bought 90,000 Cybin common shares at $11.5853 apiece for $1,042,677.
- Cybin awarded Glavine 1,046,899 restricted stock units on September 1, 2026.
- PLG family trust is associated with 336,204 shares, representing 0.4% of the reported interest.
Paul Glavine and PLG Family Trust report a 5.8% beneficial interest in Cybin Inc. (NASDAQ: HELP), with Glavine serving as the company’s chief growth officer and a Trustee of the trust.
Glavine Adds Shares and Receives Restricted Units
Glavine purchased 90,000 Cybin common shares on August 31, 2026, paying $11.5853 per share for a total of $1,042,677. Cybin awarded him 1,046,899 restricted stock units on September 1, 2026. The reported holdings were acquired through personal funds or employee incentive awards, while the trust used its Working Capital for its holdings. The stated purpose covers Investment activity and issuer employee incentive awards. The trust’s reported position totals 336,204 shares and represents 0.4%.
FAQs
Q: How many Cybin shares did Paul Glavine buy?
A: Paul Glavine purchased 90,000 Cybin common shares on August 31, 2026. The purchase price was $11.5853 per share, producing a total cost of $1,042,677.
Q: What is Paul Glavine’s reported Cybin stake?
A: Glavine and PLG Family Trust report a 5.8% beneficial interest in Cybin. Glavine holds sole authority over 4,071,252 directly held common shares.
Q: How many restricted stock units did Cybin award Glavine?
A: Cybin awarded Paul Glavine 1,046,899 restricted stock units on September 1, 2026. Glavine is the company’s chief growth officer and a trustee of PLG Family Trust.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.